Company news

Ribomic, Inc. news in 2022

Ribomic, Inc.'s news releases, calls and decks from 2022, newest first.

View company

RIBOMIC Announces Issuance of US Patent for its RBM-010, Novel Drug Candidate for Osteoarthritis

July 29, 2022

RIBOMIC Announces Completion of IND submission for an Observational Study for Continuous Phase 2 Trial of RBM-007 for Treatment of Achondroplasia

April 19, 2022

RIBOMIC Provides Update on RBM-007 Program in Wet Age-Related Macular Degeneration

March 23, 2022

RIBOMIC Announces Presentation Materials of the 40th Annual J.P. Morgan Healthcare Conference

January 11, 2022

Decks in 2022